NFKBIA and cancer: EGFR signaling activates NF-κB via the IKK complex and IκBα (Shostak and Chariot, 2015), whereas inhibition of NF-κB is a common feature of several members of the cardenolide glycoside family related to cancer cell mitotic arrest and apoptosis (39–41).